ImmunityBio Inc. Common Stock vs Pan American Silver Corp. Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10.53 (market cap $10.51B), while Pan American Silver Corp. Common Stock trades at $46.32 (market cap $18.72B). The key difference: Pan American Silver Corp. Common Stock is the larger of the two by market cap, and Pan American Silver Corp. Common Stock pays a 1.62% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 1 Days and Pan American Silver Corp. Common Stock for 1 Days on average.
| IBRX | PAAS | |
|---|---|---|
Market Cap | $10.51B | $18.72B |
Volume | 10,445,785 | 2,957,838 |
Sector | Health | Basic Materials |
52-Week High | $11.55 | $68.70 |
52-Week Low | $1.98 | $33.20 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $10.97B | $17.86B |
Dividend Yield | — | 1.62% |
Trailing returns across standard periods
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →Pan American Silver is a mining company focused on silver and gold production in the Americas. It also explores and develops precious metals properties.
Read more on PAAS →